GDR vs. AGL, YGEN, ABDX, PRM, GENI, VRCI, DMTR, LLAI, LLA, and IDHC
Should you be buying genedrive stock or one of its competitors? The main competitors of genedrive include ANGLE (AGL), Yourgene Health (YGEN), Abingdon Health (ABDX), Proteome Sciences (PRM), GENinCode (GENI), Verici Dx (VRCI), Deepmatter Group (DMTR), LungLife AI (LLAI), LLA.L,0P0001T9GN,0 (LLA), and Integrated Diagnostics (IDHC). These companies are all part of the "diagnostics & research" industry.
genedrive vs. Its Competitors
ANGLE (LON:AGL) and genedrive (LON:GDR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, media sentiment, valuation, risk, analyst recommendations and institutional ownership.
In the previous week, ANGLE's average media sentiment score of 0.00 equaled genedrive'saverage media sentiment score.
ANGLE currently has a consensus price target of GBX 40, indicating a potential upside of 515.38%. Given ANGLE's stronger consensus rating and higher possible upside, research analysts plainly believe ANGLE is more favorable than genedrive.
genedrive has lower revenue, but higher earnings than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than genedrive, indicating that it is currently the more affordable of the two stocks.
18.8% of ANGLE shares are held by institutional investors. Comparatively, 0.3% of genedrive shares are held by institutional investors. 16.2% of ANGLE shares are held by company insiders. Comparatively, 14.8% of genedrive shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
ANGLE has a net margin of -890.91% compared to genedrive's net margin of -1,412.18%. ANGLE's return on equity of -76.01% beat genedrive's return on equity.
ANGLE has a beta of 0.22, suggesting that its stock price is 78% less volatile than the S&P 500. Comparatively, genedrive has a beta of -0.04, suggesting that its stock price is 104% less volatile than the S&P 500.
Summary
ANGLE beats genedrive on 11 of the 14 factors compared between the two stocks.
Get genedrive News Delivered to You Automatically
Sign up to receive the latest news and ratings for GDR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding GDR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
genedrive Competitors List
Related Companies and Tools
This page (LON:GDR) was last updated on 7/8/2025 by MarketBeat.com Staff
